MUC5B genotype affects survival of patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment
D. Biondini (Padova, Italy), E. Balestro (Padova, Italy), C. Rigobello (Padova, Italy), S. Baraldo (Padova, Italy), D. Lacedonia (Foggia, Italy), E. Cocconcelli (Padova, Italy), E. Bazzan (Padova, Italy), M. Foschino Barbaro (Foggia, Italy), M. Cosio (Montreal, Canada), M. Saetta (Padova, Italy), P. Spagnolo (Padova, Italy)
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Biondini (Padova, Italy), E. Balestro (Padova, Italy), C. Rigobello (Padova, Italy), S. Baraldo (Padova, Italy), D. Lacedonia (Foggia, Italy), E. Cocconcelli (Padova, Italy), E. Bazzan (Padova, Italy), M. Foschino Barbaro (Foggia, Italy), M. Cosio (Montreal, Canada), M. Saetta (Padova, Italy), P. Spagnolo (Padova, Italy). MUC5B genotype affects survival of patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment. 1352
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: